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Abstract
We used quantitative real-time PCR to examine the expression of 112 genes related to retinal function and/or
belonging to known pro-apoptotic, cell survival, and autophagy pathways during photoreceptor degeneration
in three early-onset canine models of human photoreceptor degeneration, rod cone dysplasia 1 (rcd1), X-
linked progressive retinal atrophy 2 (xlpra2), and early retinal degeneration (erd), caused respectively, by
mutations in PDE6B, RPGRORF15, and STK38L. Notably, we found that expression and timing of
differentially expressed (DE) genes correlated with the cell death kinetics. Gene expression profiles of rcd1
and xlpra2 were similar; however rcd1 was more severe as demonstrated by the results of the TUNEL and
ONL thickness analyses, a greater number of genes that were DE, and the identification of altered expression
that occurred at earlier time points. Both diseases differed from erd, where a smaller number of genes were
DE. Our studies did not highlight the potential involvement of mitochondrial or autophagy pathways, but all
three diseases were accompanied by the down-regulation of photoreceptor genes, and up-regulation of several
genes that belong to the TNF superfamily, the extrinsic apoptotic pathway, and pro-survival pathways. These
proteins were expressed by different retinal cells, including horizontal, amacrine, ON bipolar, and Müller cells,
and suggest an interplay between the dying photoreceptors and inner retinal cells. Western blot and
immunohistochemistry results supported the transcriptional regulation for selected proteins. This study
highlights a potential role for signaling through the extrinsic apoptotic pathway in early cell death events and
suggests that retinal cells other than photoreceptors might play a primary or bystander role in the degenerative
process.
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Abstract
We used quantitative real-time PCR to examine the expression of 112 genes related to retinal function and/or
belonging to known pro-apoptotic, cell survival, and autophagy pathways during photoreceptor degeneration in three
early-onset canine models of human photoreceptor degeneration, rod cone dysplasia 1 (rcd1), X-linked progressive
retinal atrophy 2 (xlpra2), and early retinal degeneration (erd), caused respectively, by mutations in PDE6B,
RPGRORF15, and STK38L. Notably, we found that expression and timing of differentially expressed (DE) genes
correlated with the cell death kinetics. Gene expression profiles of rcd1 and xlpra2 were similar; however rcd1 was
more severe as demonstrated by the results of the TUNEL and ONL thickness analyses, a greater number of genes
that were DE, and the identification of altered expression that occurred at earlier time points. Both diseases differed
from erd, where a smaller number of genes were DE. Our studies did not highlight the potential involvement of
mitochondrial or autophagy pathways, but all three diseases were accompanied by the down-regulation of
photoreceptor genes, and up-regulation of several genes that belong to the TNF superfamily, the extrinsic apoptotic
pathway, and pro-survival pathways. These proteins were expressed by different retinal cells, including horizontal,
amacrine, ON bipolar, and Müller cells, and suggest an interplay between the dying photoreceptors and inner retinal
cells. Western blot and immunohistochemistry results supported the transcriptional regulation for selected proteins.
This study highlights a potential role for signaling through the extrinsic apoptotic pathway in early cell death events
and suggests that retinal cells other than photoreceptors might play a primary or bystander role in the degenerative
process.
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Introduction
The visual process is initiated by quantal light absorption by
opsin visual pigments and signal generation, first in the
photoreceptor (PR) cells and subsequently through two
complex synaptic pathways in the outer and inner plexiform
layers to convey the information to higher visual centers. The
intricate structure of highly differentiated PRs is ideally suited
for light absorption and signal transduction, and is highly
dependent on the expression of multiple genes involved, first in
PR specification, and then differentiation and maintenance [1].
In humans, 232 loci are associated with retinal degeneration; of
these 192 have been identified as the causative genes
(RetNet: http://www.sph.uth.tmc.edu/RetNet/; June 2013). A
comparable, albeit smaller, number of genes are associated
with retinal degeneration in animals [2,3].
PR death is a common fate in retinal degenerations
(reviewed by [4]) and occurs through a variety of molecular
mechanisms and in response to multiple genetic or acquired
insults [5]. Disease-associated PR cell death has been
reported to occur via apoptosis [6,7], and several studies have
implicated various mechanisms and pathways involved in
retinal cell death [8-12]. A compensatory but imperfect survival
response also occurs [12,13]. Disease-specific cell death and
survival responses depend on the underlying mutation, whether
the disease occurs naturally or is induced, the speed of the
degenerative process, the cell types involved, and many other
factors [10,12].
Although the causative genetic mutations resulting in PR
disease are often well characterized, the molecular events that
link the mutation to cell death are still unknown. Indeed,
because of experimental limitations when working with human
subjects, e.g. lack of adequate sample numbers at the
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appropriate disease stages, studies of retinal degeneration
mechanisms rely heavily on the use of corresponding animal
models. In dogs, inherited retinopathies occur and result from
mutations in multiple genes [3]. In the present study we used
three canine retinal disease models-rcd1, xlpra2, and erd-to
examine the molecular mechanisms of cell death. Both rcd1
[14,15] and xlpra2 [16] bear mutations in genes, rod cyclic
GMP phosphodiesterase ß subunit (PDE6B) and retinitis
pigmentosa GTPase regulator (RPGR), respectively, that
cause human inherited blindness, and the disease phenotypes
are similar and comparable. For erd (Serine/Threonine Kinase
38 Like/ STK38L-mutant), no equivalent disease has been
reported in humans [17]. In all three, the early and rapid
degeneration of the PRs makes the disease course predictable
and highly suitable for comparative studies of the degenerative
events. The exact mechanisms by which mutations in these
genes drive the disease progression are currently unknown. As
a first step in trying to characterize disease progression, we
looked at expression changes in genes that might be involved
with PR death in the three canine models. To this end, we used
quantitative real-time PCR (qRT-PCR) with a custom-made
canine specific profiling array [18] or single gene assays and
examined the retinal expression of several genes that are
related to vision or belong to the best described pro-apoptotic
(either mitochondria-related or not), pro-survival (as down-
regulation may indirectly cause cell death), and autophagy
pathways.
The complete list of genes analyzed in this study with the
corresponding descriptions is reported in Table S1. Expression
profiles were tested at the most relevant disease-related
phases of PR cell death [19,20]: before cell death peak
(induction; 3 wks); at cell death peak (execution; 5 and 7 wks);
during sustained but reduced cell death rate (chronic cell
death; > 14 wks). Our results indicate that in all three diseases,
the majority of differentially expressed (DE) genes belong to
the TNF superfamily and the extrinsic apoptotic pathway, and
that several of them are produced by non-PR cells. Moreover,
as changes in the expression of several genes were common
between the three diseases, our results suggest that although
different genes/mutations initiate the diseases, there may be a
commonality in the signaling pathways that eventually lead to
PR death.
Results
Morphological changes and time course of PR cell
death in early-onset retinal degeneration models
As previously reported for rcd1, xlpra2, and erd, retinal
development is initially normal, but PR abnormalities and
retinal degeneration begin at different time points [19,21,22];
these differences are illustrated in Figure S1. We used TUNEL
assays to determine the kinetics of PR cell death in rcd1, and
compared the results to previous studies in xlpra2 [19] and erd
[20]. While the normal retina shows only background TUNEL
positive cells between 4-14 wks of age, the rcd1 retina already
has a high number of dying cells at 2 wks of age, well before
there is thinning of the outer nuclear layer (ONL) (Figure 1A,
B). The peak of PR cell death occurs at ~5 wks, and sustained
numbers of TUNEL positive cells are present from 5-7.7 wks.
Although the number of TUNEL positive cells declines
thereafter, it remains 100-150 fold higher than background
through the 20 wks time period.
Decreases in ONL thickness, an indication of PR loss, follow
a comparable course to the apoptotic events. It occurs more
rapidly and aggressively in rcd1 and slightly delayed in xlpra2.
However, in erd the ONL thickness is preserved until at least
14.1 wks due to concurrent PR proliferation which is
concomitant with apoptotic events [20]. At the time points
examined, inner retinal neurons and Müller glial cells were
morphologically normal.
Figure 1.  Time course of cell death in study models.  A) TUNEL-positive PR cells as a function of age (wks) in the superior
retinal meridian of normal, rcd1, xlpra2, and erd-mutants. Mean ± SD of 3 measurements taken from the superior retinal meridian of
each dog are reported. B) ONL thickness as number of rows of PR nuclei in normal, rcd1, xlpra2, and erd-mutants as a function of
age (wks). Mean ± SD of 3 measurements taken from the central and midperipheral regions of the superior retinal meridian of each
dog. xlpra2 data are slightly modified from [19] and erd from [20].
doi: 10.1371/journal.pone.0085408.g001
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Gene and protein expression changes with disease: PR
and retinal enriched genes
To assess the status of the retina, we first examined the
expression profiles of PR-specific genes as well as other genes
preferentially expressed in the retina. Comparison of mutant vs.
normal did not show any expression changes at 3 wks of age,
but there were a number of DE genes at older ages (Figure
2A). With the exception of CNGB3 at 7 wks in rcd1 and xlpra2,
only glial fibrillary acidic protein (GFAP) and vimentin (VIM)
were up-regulated. As these genes are preferentially
expressed in Müller cells, such expression is likely an inner
retinal stress response to outer retinal disease. The highest
numbers of DE genes, all down-regulated, were found in rcd1,
reinforcing the fact that this disease is earlier in onset and more
aggressive. The fold changes (FC) differences with normal of 5
selected genes, rhodopsin (RHO), S-opsin (OPN1SW), L-opsin
(OPN1LW), S-antigen (SAG), and cyclic nucleotide gated
channel beta 3 (CNGB3) as a function of time are shown in
Figure 2B. The results for the first 4 genes illustrate the general
down-regulation in expression in the three diseases with rcd1
showing a greater decrease in RHO and SAG early, but no
significant changes in cone opsins until 16 wks, and then
limited to OPN1SW. On the other hand, the cone-specific gene
CNGB3 was up-regulated in rcd1 and xlpra2 at 7 wks, but did
not vary at the other ages (Figure 2B), suggesting that the
expression of this gene is not correlated with the observed loss
of cones.
To correlate gene expression changes at the mRNA and
protein levels, western analysis was undertaken for selected
retinal proteins. There was decreased RHO levels in rcd1 from
the 5 wk time point which decreased in parallel with PR cell
loss; for xlpra2 and erd, decreases occurred later. Decreases
in SAG levels were more modest and occurred at all ages in
rcd1 and at 16 wks in xlpra2-mutant retinas (Figure 3A and
western blot quantification in Table S2). Immunolabeling results
showed marked mislocalization of RHO from the outer
segments to the ONL and outer plexiform layer (OPL) at all
time points, and of SAG at later time points. An antibody
directed against cone-specific arrestin (ARR3) was used to
label the entire cone structure, and confirmed that cone cells
were present, although structurally altered, in the three
diseases (Figure 3B). Cell body labeling with ARR3 was
present in xlpra2-mutants at early disease time points (4-5 wks)
and persisted during the course of disease (Figure 3B). Similar
findings have been observed in normal dogs and other mutants
as well [23,24]. ARR3 labeling in erd-mutants is specific but
irregular, and likely results from the continuing proliferation of
PRs which, presumably, are forming new axons/synaptic
terminals [20,22].
Together, our results demonstrate that significant changes in
expression of a subset of the retinal genes occur and are
concomitant with the onset of PR degeneration.
Gene and protein expression changes with disease:
pathway analysis
To determine how expression profiles changed as a result of
disease, we compared the mutant dogs to normal controls at
different ages. The results for a select subset of genes is
presented in Table 1 and showed an increased expression of
genes of the TNF superfamily and/or the extrinsic apoptotic
pathway (comprising ligands, receptors, regulators, caspases,
and suppressors), and pro-survival factors (neurotrophins and
transcription factors). The results for all the genes are included
in Table S3. To further delineate gene expression profiles with
disease status, we discuss below relevant changes during
different phases of the disease.
Induction and execution phases.  Based on the early
onset of retinal degeneration in rcd1, we expected to see an
increase in death-associated genes. In support of this
observation, 8 genes were DE by the time cell death was
initiated in rcd1 (3 wks), and all were up-regulated (Table S3).
Four of these were members of the TNF superfamily and/or the
extrinsic apoptotic pathway (Table 1). At 5 wks, the peak of cell
death, 12 genes were DE (10 up- and 2 down-regulated) in
rcd1 relative to normals (Table S3). These included 5 TNF
superfamily and/or extrinsic apoptotic pathway members and 2
pro-survival factors; 3 of these genes were already up-
regulated at 3 wks (Table 1). Down-regulated were two pro-
survival genes: XIAP, a potent inhibitor of the extrinsic
apoptotic pathway and PRDX3, a mitochondrial antioxidant
protein that regulates NFkB. At 7 wks, there were 39 up-
regulated genes, and only XIAP (Table 1) and SLC25A5 were
decreased in expression (Table S3). In contrast to the results
of PR/retinal genes, DE genes were already apparent in rcd1 at
3 wks, indicating that changes in gene expression precede the
main morphological retinal changes and suggesting that at
least some of the pathways driving degeneration are already
engaged at this point.
In accordance with the later disease onset and less severe
PR structural abnormalities in xlpra2, there were no changes in
gene expression relative to normal retinas at the 3 and 5 wk
time points, which was in agreement with the PR/retinal gene
expression data (Figure 2 and Table S3). However at 7 wks, 18
genes were up-regulated, and 7 of these genes were also up-
regulated at the 5 wk time period in rcd1. A comparison of the
18 DE genes in xlpra2 at 7 wks with rcd1 at the same age
shows that 17 of 18 genes were identical and showed the
same pattern of regulation. The only exception was CASP3,
which was found to be up-regulated only in xlpra2. These data
further suggest that although rcd1 and xlpra2 are caused by
different mutations, the changes in gene expression profiles
are similar, with only small differences in the kinetics of
expression.
A smaller number of time points were available for erd. No
differences in expression were found between 6.4 wks old
mutants and 7 wks normals. However, at 8.3-9.9 wks, 6 genes
(CD40LG, HSP90, STAT3, TNFA, TNFRSF1A, TNFRSF9)
were up-regulated, and these were also DE in rcd1 and xlpra2
(Table S3). Of these, two are TNF superfamily ligands, two
TNF superfamily receptors, and one a pro-survival transcription
factor (Table 1). These findings suggest that similar
mechanisms may be involved in triggering the cell death
cascade in all three diseases. Moreover, the higher number of
DE genes found in rcd1 relative to both other diseases and the
relative kinetics of cell death support the observations that rcd1
is the more aggressive disease. The limited expression
TNF Superfamily Genes and Photoreceptor Disease
PLOS ONE | www.plosone.org 3 December 2013 | Volume 8 | Issue 12 | e85408
changes observed in erd indicate that cell death is not the
major disease feature at this age.
Chronic cell death phase.  This disease phase is
characterized by a lower rate but continuous cell death
process, particularly in rcd1 and xlpra2, which is associated
with a similar pattern of decreased ONL thickness. We
identified many DE genes in signaling pathways in the three
mutants at this phase, most of which were up-regulated: 42 in
rcd1, 37 in xlpra2, and 8 in erd (Table S3). As at the 7 wk time
point, all up-regulated genes in erd were also up-regulated in
the other two diseases. XIAP was down-regulated in both rcd1
and xlpra2, and SLC25A5 was also down-regulated in the latter
(Table S3). A total of 15 genes belonging to the selected
functional groups were DE in both rcd1 and xlpra2, but not erd
(note that a smaller number of genes were evaluated in erd at
this age; see Material and Methods), while 3 and 1 were rcd1-
or xlpra2-specific, respectively (Table 1).
When comparing the DE genes at 16 wks relative to 7 wks,
we identified several common gene expression signatures.
Specifically, up-regulation of 5 genes that belong to either the
TNF superfamily, the extrinsic apoptotic pathway, or are a pro-
survival transcription factor (CD40LG, STAT3, TNFA,
TNFRSF1A, TNFRSF9) was found in all three diseases at both
time points (Table 1). Additionally, a number of genes that
belong to the same functional groups (CASP8, NTF3, TNFSF8,
TRADD) were up-regulated in rcd1 and xlpra2, but not erd, at
Figure 2.  RNA expression changes of retinal genes in study models.  A) Differentially expressed (DE) retinal genes in rcd1,
xlpra2, and erd-mutants compared to normals at 5, 7, and 16 wks. No differences were found at 3 wks. DE genes are listed in
alphabetical order, first the up-regulated and then the down-regulated, and are reported with the fold change (FC) differences. Note
that in erd at 11.9-14.1 wks a reduced number of genes was tested (see Material and Methods). The complete list of tested genes is
in Table S1. n.s. = not statistically significant differences; n.t. = not tested. B) FC differences between rcd1, xlpra2, and erd
compared to normals at different ages (3, 5, 7, 16 wks) for RHO, OPN1SW, OPN1LW, SAG, and CNGB3. An asterisk indicates
statistical significance, bars show SD of biological triplicates.
doi: 10.1371/journal.pone.0085408.g002
TNF Superfamily Genes and Photoreceptor Disease
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both ages (Table 1). These findings show that, although the
three diseases are non-allelic, common signaling pathways are
shared among the three and extend from the execution phase
to the chronic cell death phase.
Figure 3.  Protein expression changes of RHO, SAG, and ARR3 in study models.  A) Western blot analysis of normal, rcd1,
xlpra2, and erd retinas showed decreased levels of the rod-specific protein RHO in the tested mutants at 5, 7, and 16 wks.
Decreased levels compared to normals were also observed for SAG, a major protein of the retinal rod outer segments in rcd1 at 5,
7, and 16 wks and in xlpra2 at 16 wks. The quantification of the bands illustrated in the Figure is reported in Table S2. B)
Immunolabeling of normal (4, 7, 16 wks), rcd1 (5, 7, 16 wks), xlpra2 (5, 7, 16 wks), and erd (4.3, 8.3, 14.1 wks) retinas with
antibodies against RHO, the cone-specific ARR3, and SAG. An asterisk denotes mislocalization of RHO and SAG in the inner retina
of mutants. Note that the findings are representative for the entire retina. Scale bar: 20 μm; PR = photoreceptors; ONL = outer
nuclear layer; OPL = outer plexiform layer; INL = inner nuclear layer.
doi: 10.1371/journal.pone.0085408.g003
TNF Superfamily Genes and Photoreceptor Disease
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3 wks    
CASP8 (C) 2.3 n.s.  
CD40LG (L) 2.6 n.s.  
FAS (RE) 2.2 n.s.  
TNFA (L) 3.5 n.s.  
5 wks    
CASP8 (C) 2.1 n.s.  
FAS (RE) 2.6 n.s.  
NTF3 (N) 6.1 n.s.  
STAT3 (T) 3.4 n.s.  
TNFA (L) 2.6 n.s.  
TNFRSF1A (RE) 7.7 n.s.  
XIAP (S) -2.4 n.s.  
7 wks   FC erd (8.3-9.9 wks)vs. 7 wks normal
BDNF (N) 3.1 n.s. n.s.
CASP3 (C) n.s. 2.1 n.s.
CASP8 (C) 2.8 2.1 n.s.
CD40LG (L) 30.9 15.1 3.8
FADD (RG) 2.7 n.s. n.s.
FAS (RE) 2.9 n.s. n.s.
FASLG (L) 4.5 n.s. n.s.
NGF (N) 3.5 n.s. n.s.
NTF3 (N) 32.1 2.7 n.s.
NTF4 (N) 4.9 n.s. n.s.
STAT3 (T) 5.1 2.4 3.7
TNFA (L) 11.2 4.3 5.3
TNFRSF1A (RE) 26.3 9.3 9.1
TNFRSF9 (RE) 5.1 4.0 3.3
TNFRSF25 (RE) 2.8 n.s. n.s.
TNFSF8 (L) 14.5 9.2 n.s.
TRADD (RG) 2.6 2.9 n.s.
TRAF3 (RG) 2.0 n.s. n.s.
XIAP (S) -2.0 n.s. n.s.
16 wks   FC erd (11.9-14.1 wks)vs. 16 wks normal
BDNF (N) 2.0 n.s. n.s.
CASP3 (C) 2.1 2.0 n.s.
CASP8 (C) 8.2 4.3 n.s.
CD40 (RE) 2.3 n.s. n.s.
CD40LG (L) 8.2 11.8 4.0
FADD (RG) 3.6 2.4 n.s.
FAS (RE) 8.8 3.2 n.s.
FASLG (L) 7.5 5.0 n.s.
NFKB1 (T) 3.4 2.0 n.s.
NGF (N) 3.5 2.6 n.s.
NTF3 (N) 42.2 48.8 n.s.
NTF4 (N) 4.9 n.s. n.s.
RIPK1 (RG) 3.4 2.6 n.s.
RIPK3 (RG) 9.5 3.2 n.s.
STAT3 (T) 4.7 4.3 3.3
TNFA (L) 25.0 9.5 5.9
Fold change differences for selected genes belonging to
different gene categories.  The profiling array results
highlighted a potential role in the degeneration process for
genes of the extrinsic apoptotic pathway and those having a
pro-survival function. To better illustrate these results we
displayed FC differences compared to normals at different
ages for selected genes representing these functional
categories (Figure 4A: pro-death members of the extrinsic
apoptotic pathway; 4B: pro-survival genes). With the exception
of XIAP, there is an increased expression of all these genes.
The magnitude and time course of expression directly reflected
the severity and rate of progression of the diseases, being
earlier and of greater magnitude in rcd1. These data suggest
that although apoptotic pathways are activated during the
disease process, counteracting pro-survival mechanisms are
also engaged, albeit to a lesser extent.
Protein analysis of selected DE genes.  To assess the
differential RNA expression results of the pathway analysis at
the protein level, DE genes representing different functional
groups that were differentially regulated in diseased dogs were
selected for analysis by western blot and/or IHC at relevant
time points. These included TNF superfamily members and/or
members of the extrinsic apoptotic pathway, as well as pro-
survival genes.
Pro-death members of the extrinsic apoptotic pathway
are up-regulated during early PR degeneration.  We initially
tested protein expression of TNF superfamily ligands TNFA,
CD40LG, and TNFSF8. TNFA was slightly up-regulated in rcd1
at 5 wks and in the three mutant retinas at 7-8.3 wks. At 16
wks, samples were only available for rcd1 and xlpra2 and
TNFA levels were elevated in both (Figure 5, Table S2). A
similar expression pattern was observed for CD40LG and
TNFSF8, although the latter was markedly higher at 7 wks in
xlpra2 and at 16 wks in rcd1, but did not vary at 8.3 wks in erd







TNFRSF1A (RE) 7.3 8.8 4.1
TNFRSF9 (RE) 3.2 3.9 4.1
TNFRSF25 (RE) 2.9 2.9 n.s.
TNFSF8 (L) 16.2 9.0 n.s.
TNFSF10 (L) 9.3 4.5 n.s.
TRADD (RG) 3.2 3.7 n.s.
TRAF3 (RG) n.s. 2.2 n.s.
XIAP (S) -2.3 -2.0 n.s.
Selected DE genes identified by qRT-PCR in rcd1, xlpra2, and erd-mutants
compared to normals at 3, 5, 7, and 16 wks of age. DE genes belong to the TNF
superfamily and/or extrinsic apoptotic pathway [ligands (L), receptors (RE),
regulators (RG), caspases (C), suppressors (S)], are pro-survival neurotrophins (N)
or transcription factors (T). They are listed in alphabetical order and are reported
with the FC differences. n.s. = not statistically significant differences. Note that in
erd at 11.9-14.1 wks a reduced number of genes were tested (see Material and
Methods). The complete list of tested genes is available as Table S1.
doi: 10.1371/journal.pone.0085408.t001
TNF Superfamily Genes and Photoreceptor Disease
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identify the cells and retinal layers in which the protein
expression changes occurred. Indeed, to specifically identify
positive cells, dual-labeling of selected proteins with either Go-
α (marker for ON bipolar cells), parvalbumin (marker for
horizontal and amacrine cells), or CRALBP (marker for Müller
cells) was performed. In normal retinas, TNFA was localized to
the RPE only in young dogs at 5 wks (data not shown), to the
PR layer at 7 wks, and to the inner retina, in particular to Müller
cell end feet (Figure S2), at all ages examined. This distribution
pattern was also present in rcd1, xlpra2, and erd but labeling
was more intense and expression persisted in the RPE and
remaining cone inner segments at all ages (Figure 6).
Localization of CD40LG and TNFSF8 in mutant retinas was
comparable to normal, although expression levels were higher
(Figure 6). Both proteins were found in the inner retina,
CD40LG mainly in the GCL, where it co-localized with Müller
cell end feet (Figure S2), while TNFSF8 was observed in all
layers, and co-localized with Müller, horizontal, and ON bipolar
Figure 4.  RNA expression changes of selected pro-death and pro-survival genes in study models.  The fold change (FC)
differences measured by qRT-PCR of selected genes in mutants compared to normals are shown at different ages. Genes belong
to different functional categories: A) pro-death members of the extrinsic apoptotic pathway CASP8, TNFA, TNFRSF1A, TRADD; B)
pro-survival STAT3, NTF3, XIAP, IL10. An asterisk indicates statistical significance; bars show SD of biological triplicates. Note that
values on the Y-axis are not the same for all graphs, due to the highly variable FC differences in gene expression.
doi: 10.1371/journal.pone.0085408.g004
TNF Superfamily Genes and Photoreceptor Disease
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cells (Figure S2). Interestingly, the retraction of ON bipolar
dendrites previously reported in xlpra2 compared to normals
[25] is clearly visible with Go-α (Figure S2). These data show
that while all 3 TNF superfamily ligands are present in Müller
cells, TNFSF8 also appears to localize in other inner retinal
neurons.
We next examined the expression of the TNF superfamily
receptors TNFRSF1A and TNFRSF9, and the interacting
regulator TRADD. Western analysis showed that while
expression of TNFRSF1A was marginally increased in the
three mutants, TNFRSF9 and TRADD were up-regulated in the
execution and chronic cell death phases (Figure 5, Table S2).
By IHC, the localization of these proteins was comparable to
normal, and increased labeling was found in erd at 7.7 wks and
rcd1 at 16 wks. IHC localized TNFRSF1A mainly to the OPL in
all tested retinas and to a lesser extent to the inner retina. In
normals at 7 and 16 wks, the staining intensity was lower than
in the age-matched mutants, in particular the 7.7 wks erd and
the 7 and 16 wks rcd1 (Figure 6). Confocal microscopy showed
that TNFRSF1A co-localized with the horizontal cell lateral
extensions in both normal and mutants (Figure S2), while the
protein was not present in ON bipolar cells (data not shown).
Both TNFRSF9 and TRADD, a regulatory protein that can bind
to TNFRSF1A, were localized to the INL, and to a lesser
Figure 5.  Protein quantification by western blot in retinas of study models.  Protein expression of TNF superfamily ligands
(TNFA, CD40LG, TNFSF8), TNF superfamily receptors (TNFRSF1A, TNFRSF9), TNF superfamily regulator TRADD, initiator
caspase CASP8, and pro-survival molecules STAT3, NTF3, and XIAP were analyzed at different ages of normal, rcd1, xlpra2, and
erd retinas. Up-regulation of TNFA and CD40LG was found in mutants at all ages, particularly at 7-8.3 and 16 wks. TNFSF8
expression was markedly higher in xlpra2 at 7 wks and rcd1 at 16 wks. TNFRSF1A was marginally increased in mutants at all ages,
while TNFRSF9, TRADD, and active CASP8 were up-regulated at 7-8.3 and 16 wks. Active CASP8 was also increased in rcd1 at 5
wks. Both STAT3 and NTF3 were up-regulated in mutants at all ages, whereas XIAP expression decreased in mutants after 7 wks,
and was particularly low in rcd1 at 7 wks. Either ACTB or GAPDH were used as loading controls. White spaces indicate that the gel
was cut. Approximate molecular size markers are indicated. The quantification of the bands illustrated in the Figure is reported in
Table S2.
doi: 10.1371/journal.pone.0085408.g005
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extent, the GCL and NFL (only TRADD). In the INL, TNFRSF9
was present in all cell nuclei, while TRADD expression was
more limited and fewer cells were labeled (Figure 6). Both
proteins were co-localized in the OPL to few horizontal cells,
and TNFRSF9 also to amacrine cells (Figure S2). Both proteins
were not expressed by ON bipolar and Müller cells (data not
shown). These results indicate that the same cells express the
2 receptors and the adaptor molecule, but at this point, their
involvement in the PR degenerative process is unknown.
The initiator and effector caspases, CASP8 and CASP3
respectively are activated during the extrinsic apoptotic
pathway, and our mRNA data showed an increased expression
of the genes (Table 1). Western blot results showed that the 18
kDa active form of CASP8 was up-regulated in rcd1 at 5 wks,
and in mutants at 7-8.3 and 16 wks (Figure 5, Table S2), while
we could not identify the non-active form of the protein (65
kDa). IHC results showed that labeling intensity of active
CASP8 was higher in mutants compared to normal at 7 and 16
wks and that the protein mainly localized to the OPL (Figure 6)
in horizontal (Figure S2) but not ON bipolar cells (data not
shown). In contrast, western and IHC failed to identify the
specific active form of CASP3 (17 kDa) in our retinal samples
(data not shown) despite testing 5 different antibodies (Table
S4). Thus, our current data does not confirm nor reject the
hypothesis of caspase-dependent cell death in these canine
models.
Pro-survival responses are both up- and down-regulated
during early PR cell death.  We examined the expression of 3
pro-survival/anti-apoptotic proteins that were DE at the RNA
level, as well as expression of the canonical NFkB pathway
which is downstream of TNFRSF1A. In accordance with the
RNA expression results, higher STAT3 and NTF3 protein levels
Figure 6.  Retinal localization of proteins of the TNF superfamily and CASP8 in study models.  Immunolabeling of normal,
rcd1, xlpra2, and erd retinas with antibodies against TNF superfamily ligands (TNFA, CD40LG, TNFSF8); TNF superfamily
receptors (TNFRSF1A, TNFRSF9; TNF superfamily regulator TRADD; and the initiator caspase CASP8. TNFA was localized to the
inner retina in Müller cells (Figure S2) at all ages. In mutants, labeling was more intense and present in RPE and remaining cone
inner segments. CD40LG and TNFSF8 expressions were comparable to normals, although levels were higher in mutants,
particularly at 16 wks in rcd1. Both proteins were found in the inner retina, CD40LG mainly in the GCL and Müller cells (see Figure
S2), while TNFSF8 was more widely distributed and co-localized with Müller, horizontal, and ON bipolar cells (see Figure S2).
TNFRSF1A localized mainly to the OPL in horizontal cells (see Figure S2). The staining intensity was higher in mutants than in
normals, particularly in erd at 7.7 wks and rcd1 at 7 and 16 wks. TNFRSF9 and TRADD labeling was comparable in normal and
mutants, although both were slightly more intense in the latter. They both were localized to the OPL and INL, where they co-
localized with horizontal cells and TNFRSF9 also with amacrine cells (see Figure S2). TNFRSF9 was present in the majority of INL
cell nuclei, while TRADD expression was limited to fewer cells. TRADD labeling was also present transiently in PRs at 7 wks.
CASP8 mainly localized to the OPL in horizontal cells (see Figure S2), and the labeling intensity was higher in mutants compared to
normals. Scale bar: 20 μm; RPE = retinal pigment epithelium, PR = photoreceptors, ONL = outer nuclear layer, OPL = outer
plexiform layer, INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer.
doi: 10.1371/journal.pone.0085408.g006
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were found in mutants (Figure 5, Table S2). IHC results
indicated that, at 16 wks, the transcription factor STAT3 and
the neurotrophin NTF3 were primarily localized from the INL to
NFL of the inner retina, although the specific cell labeling
pattern differed (Figure 7). Labeling was similar in normals and
mutants although the latter showed higher intensity. In addition,
STAT3 localized to the soma and Müller cell end feet (Figure
S2) and, unlike NTF3, showed intense labeling of PR inner
segments at the later time point, a finding not observed in
normals (Figure 7).
On the other hand, western analysis indicated that the
expression of the anti-apoptotic XIAP decreased in rcd1 and
xlpra2 mutants beginning at 7 wks, with particularly low levels
in rcd1 (Figure 5, Table S2). In normals at 16 wks, IHC showed
intense XIAP staining in the PR layer, the OPL-INL interface,
as well as the RPE. PR-labeling was restricted to the IS, and
was not generalized to all cells (Figure 7). The same staining
pattern was also observed at earlier ages, i.e. 5-8 wks (data
not shown). By the cytological appearance and distribution, the
XIAP positive IS appeared to be cones. Dual-labeling with
monoclonal RHO and polyclonal XIAP antibodies confirmed
that the XIAP positive cells were not rods as no co-localization
was observed (data not shown). Mutant retinas showed a
similar labeling pattern as normals, particularly in xlpra2,
although the intensity was much reduced. Thus, the observed
down-regulation of this anti-apoptotic protein in cones may
contribute to the secondary loss of this cell class in rod or rod-
cone degenerations.
As the TNFA-TNFRSF1A interaction is known to lead to the
activation of the pro-survival NFkB pathway [26], we examined
the phosphorylated state of 3 key signaling molecules NFkB
p65, IKKα/β, and IKBα. Although these proteins were activated
in positive controls from dogs with relapsed B-cell lymphoma,
western blot analysis did not identify any phosphorylation of
these proteins in retinal samples. The antibodies also did not
label any normal or mutant retinal cells by IHC, despite labeling
canine tonsil tissues used as positive controls. These findings
suggest that the canonical NFkB pathway is not activated
during retinal degeneration and it is not the downstream
pathway activated by TNFA in the three tested models.
Discussion
Relevance of the study
This study examined the expression profiles of genes in
pathways relevant to PR degeneration in canine early-onset
models with the goal of identifying potential pathways and
genes that would be involved in the progression from mutation
to PR cell death. Differential expression results were consistent
Figure 7.  Retinal localization of pro-survival proteins in study models.  Immunolabeling of normal, rcd1, xlpra2, and erd
retinas at 14.3 to 16 wks with antibodies against pro-survival proteins STAT3, NTF3, and XIAP. Both STAT3 and NTF3 were
primarily localized to the inner retina, from the INL to NFL, although the labeled cells differed. Mutant retinas exhibited higher
labeling intensities and STAT3, but not NTF3, and showed intense PR inner segment labeling that was absent in normals. STAT3
also co-localized with Müller cells (see Figure S2). Mutant and normal retinas showed similar XIAP labeling pattern, although the
intensity was reduced in mutants. XIAP was found in the PR layer, including the OPL-INL interface, as well as the RPE. PR-labeling
was restricted to IS that in terms of numbers and shape appeared to be cones. An asterisk indicates that the RPE was missing.
Scale bar: 20 μm; RPE = retinal pigment epithelium, PR = photoreceptors, ONL = outer nuclear layer, OPL = outer plexiform layer,
INL = inner nuclear layer, IPL = inner plexiform layer, GCL = ganglion cell layer, NFL = nerve fiber layer.
doi: 10.1371/journal.pone.0085408.g007
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at both the RNA and protein levels, and pointed to genes and
pathways potentially involved in the disease. As transcriptome
profiling arrays require validation of a subset of DE genes by
qRT-PCR, we decided instead to develop a qRT-PCR array to
directly examine the expression of selected genes in pathways
[18]. For this analysis, time points were selected based on cell
death kinetics (Figure 1 and [19], [20]) and covered temporally
distinct phases of the disease-induction, execution, chronic cell
death-that are readily analyzed with minimal overlap.
Comparison between mutants vs. normals showed two
different expression profile patterns. Mutant retinas up-regulate
expression of several genes of the TNF superfamily, the
extrinsic apoptotic pathways, and pro-survival neurotrophins
and transcription factors, while they down-regulate PR-specific
genes. Only Müller cell GFAP expression, which reflects an
inner retinal stress response to outer retinal disease in several
retinal diseases including xlpra2 [27], was markedly elevated at
early time points. Other than the mRNA and protein expression
changes occurring in Müller cells, these cells showed no
structural changes during the time points of the disease
examined.
Although the genes and pattern of expression are similar
between diseases, the timing is not, and is dependent on the
temporal kinetics of cell death. When these are aligned, then
the similarities are striking, particularly for rcd1 and xlpra2 that
have a narrower execution phase. The delay in expression
changes in erd until 14.1 wks supports a slower disease time
course, and is consistent with the sustained apoptosis and cell
division that occurs during this time period [20].
Decreased expression of CRX, RHO, OPN1SW, and SAG
has been previously reported in xlpra2 at 16 wks [27], and
changes in PR-specific gene expression, such as down-
regulation and mislocalization of RHO to the ONL and OPL, are
in agreement with studies in mice [28,29] and dogs [19,20].
These findings provide added support that the mutant PRs are
compromised. Moreover, ARR3 expression data confirmed that
cone abnormalities occurred at later ages, after a substantial
damage to rods occurred, even though no changes were
observed in OPN1LW expression. These findings indicate that
in all three diseases a differential and preferential damage of
rods and S-cones occurs, which is dependent on the time
course and severity of the disease.
In order to investigate the effects of the mutations on disease
onset and progression, we examined for the possible activation
of intrinsic and/or extrinsic pathways of cell death in the retina.
It is possible that the approach used may have missed genes
not included in the array, or molecular pathways that involve
post-translational activation and not expression changes at the
transcript level. In spite of these limitations, our results
identified alterations in the expression of several genes and
proteins of the TNF superfamily and the extrinsic apoptotic
pathway (for reviews see [30,31]), and double-immunolabeling
techniques suggest that some of these proteins are produced
by Müller and horizontal cells.
In mutant retinas we observed increased expression of the
three TNF superfamily ligands, TNFA, CD40LG, and TNFSF8,
which were expressed by Müller glia and other retinal cells.
Activation of Müller cells is a hallmark of early PR disease, and
represents a stress response indicating early signaling events
from the outer retina to the Müller cells that may play a role
during the degeneration process. Such reactivity of glial cells
secondary to neuronal injury is also observed in human
glaucomatous eyes [32] and retinal ischemia in pigs [33]. In
addition to Müller cells, intense TNFA labeling was found in
mutant retinas, particularly in RPE and remaining PRs.
However, the principal TNFA receptor, TNFRSF1A, showed
minimal changes at the protein level, was localized to
horizontal cells as previously reported [33]. Thus, it is not clear
at this time if TNFA transmits signals to PRs indirectly through
inner retinal neurons, or directly through a receptor yet to be
identified. Alternatively, binding of TNFA to TNFRSF1A could
lead to activation of the canonical pro-survival NFkB pathway
(reviewed by [26]), but this was not supported by our finding of
lack of phosphorylation of NFkB p65, IkBα, and IKKα/β.
In glaucomatous neurodegeneration, TNFA has been
suggested to induce apoptosis via TNFRSF1A and through the
extrinsic apoptotic pathway by activation of CASP8 and CASP3
[34]. This process has been shown to be co-regulated by the
adaptor protein TRADD [31]. In addition to TNFA and
TNFRSF1A, we found increased RNA expression of CASP8,
CASP3, and TRADD. Indeed, elevated protein expression of
active CASP8 and TRADD could be confirmed by western blot
analysis, and both proteins, in addition to TNFRSF1A, were
expressed by horizontal cells. These results suggest that these
cells may play a relevant role in the disease mechanism.
However the specific interactions between these proteins and
PR degeneration still has to be determined.
The specific role of caspases in PR apoptosis remains
controversial. In models of retinitis pigmentosa, increased
CASP3 activity caused PR degeneration in transgenic S334ter
rats, tubby mice, rds and rd mice with concomitant activation of
CASP8 and mitochondrial release of cytochrome C. In contrast,
CASP3-independent apoptosis and rod death has been
reported in rd mice (reviewed by [11]). In our studies, CASP8
was slightly activated in mutants, but we could not confirm
CASP3 activation. TNFA has been shown to induce both
apoptosis and necroptosis, an alternative form of programmed
cell death that can occur when caspase-dependent apoptosis
is inhibited [35]. CASP8 plays a crucial role in both; it initiates
apoptosis and, in conjunction with FADD, negatively regulates
RIPK1/3-mediated necroptosis [35,36]. Interestingly, we found
increased FADD, RIPK1, and RIPK3 expression in rcd1 and
xlpra2 during the chronic cell death phase, when CASP8
protein expression (Figure 5) is decreasing. However, further
analyses, including later time points, to elucidate the exact role
of caspases and the necroptosis pathway in canine retinal
degeneration models will be required to ascertain the specific
roles of these proteins.
We found increased TNFRSF9 expression in mutants, and
the protein is expressed in cell nuclei and by a subset of
horizontal and amacrine cells. While TNFA-induced TNFRSF9
expression contributes to activation of regulatory T cells [37],
and promotes a STAT3/FAS dependent signaling pathway in
dendritic cells [38], the role of this receptor in the retina is not
known. As expression of FAS, its ligand FASLG, and the
adaptor TRADD were up-regulated in mutant retinas, FAS-
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mediated apoptosis may contribute to the degeneration
process in our models. In support of this hypothesis is the
finding that this apoptotic pathway, including FAS, FASLG, and
CASP8, are activated in Brown-Norway rats after retinal
detachment [39]. Moreover, the FAS pathway can also trigger a
CASP8-independent cell death pathway using RIPK (up-
regulated in this study) as effector molecule [40]. These data
suggest that in the canine models the extrinsic apoptotic
pathway and others pathways might be activated in the same
or different cell populations during PR degeneration [8].
The profiling array used in the studies also interrogated
genes with pro-survival functions. Of particular significance was
the down-regulation of XIAP, a potent anti-apoptotic protein
expressed in canine cone PRs (present study), and shown to
inhibit caspases (e.g. 3,7,9), and suppress apoptosis [41]. This
protein has a critical pro-survival role in the retina [42] and
other tissues [43], and decreased levels of expression indicate
that a compromised XIAP response may accelerate cell death.
Experimental gene delivery studies with XIAP suggest some
degree of structural and functional rescue to PRs in both acute
and chronic rodent models of retinal degeneration [44].
PR survival can also be achieved by promoting the
production of neurotrophic factors. Our studies show increased
message level of NGF, NTF3, and NTF4, and we localized
NTF3 to nuclei of most cells in the INL and ONL. We also
tested the endogenous expression of additional neurotrophic
factors, e.g. BDNF, BFGF, GDNF, CNTF, that have been
shown to protect and delay neurodegeneration in animal
models of RP (reviewed by [4]). Except for BFGF, whose
expression did not vary, BDNF, CNTF, and GDNF RNA
expression was slightly up-regulated in rcd1 at 7 and 16 wks,
while GDNF was also up-regulated in xlpra2 at 16 wks. STAT3,
a transcription factor with a neuroprotective role in PRs after
light damage [45], was also up-regulated in mutants in this
study, and was expressed not only in Müller cells, but also in
mutant PR inner segments. These results further indicate that
multiple pathways with opposing functions and levels of
response, some pro-death and others pro-survival, are
activated during the degeneration process, likely contributing to
the timing and severity of the disease.
A previous study indicated that PR-derived EDN2 functions
as a general stress signal to Müller cells by binding to EDNRB
[46]. In this study, slight up-regulation of EDN2 occurred
without changes in EDNRB expression. This suggests that this
mechanism might not be involved in the cross-talk between
PRs and Müller cells in our models.
We previously reported that a number of non-apoptotic
genes related to mitochondria were altered in xlpra2-mutants
[27], but the present results do not support an involvement of
the apoptotic mitochondrial pathway in the degeneration
process. No differences were found in the expression of the
apoptogenic factors, or the BCL2-family members that are key
players in the execution of the mitochondrial apoptotic pathway
[11]. Although few genes of the latter family were slightly up-
regulated in rcd1 (anti-apoptotic: BCL2 at 7 wks; pro-apoptotic:
BAK1 at 7 wks and BBC3 at 3, 7, 16 wks), their opposite role
and the limitation to one disease and specific time-points
indicate that they might not be relevant components of a
general degenerative process. Retinal degeneration in different
mouse models has been reported to occur from non-apoptotic
mechanisms involving changes in cyclic nucleotide metabolism
(i.e. down-regulation of CREB and up-regulation of calpains
[9]), and induction of autophagy with activation of cathepsins
[8,10]. In our study, we also found an age specific up-regulation
of some calpains and autophagy related genes, but others, e.g.
CREB1, CTSD, and ATG3, -6, -7, -12, did not change in any of
the diseases. These results suggest that, in contrast to the
mouse models, cyclic nucleotide metabolic abnormalities or the
autophagy pathway are not essential mechanisms. However,
before excluding them and the mitochondrial pathway as being
involved in PR degeneration, additional analyses at the protein
level, including the examination of post-transcriptional
modifications, are needed.
Based on our results, we propose that a complex death
regulatory network is present in retinal cells in which TNFA-
mediated signaling pathways, horizontal and Müller cells
appear to play a relevant role and may act in conjunction with
multiple diverse other apoptosis and/or pro-survival promoting
gene products and pathways that are yet to be defined. Other
cells might also contribute to the degeneration process, as
several DE expressed genes identified in this study, e.g. CCL2,
CD18, CD40LG, CD45, STAT3, TNFA, TYROBP, have been
shown to activate or be expressed by microglia, but further
studies are warranted to confirm this hypothesis. The possibility
that activation of TNFA-related pathways in horizontal and
Müller cells is detrimental or favorable to the PR can be tested
with inhibitors. Positive modulation of the disease would
suggest that they have a pro-death role, while worsening of the




The research was conducted in full compliance and strict
accordance with the Association for Research in Vision and
Ophthalmology (ARVO) Resolution on the Use of Animals in
Ophthalmic and Vision Research. The protocol (number:
801870) was approved by the University of Pennsylvania
Institutional Animal Care and Use Committee (IACUC). All
efforts were made to minimize dog suffering.
Tissue samples
Age-matched normal and mutant dogs with a common
genetic background were maintained at the Retinal Disease
Studies Facility in Kennett Square, Pennsylvania, and retinal
tissues were collected as previously reported [27]. Three
different canine models were used for the studies: a) rod cone
dysplasia 1 (rcdl) is an early-onset, autosomal recessive rod
disease caused by a nonsense mutation in the rod-specific
cyclic GMP phosphodiesterase ß subunit (PDE6B) that results
in a stop codon and truncation of the protein by 49 aa [14,15].
The mutation in PDE6B results in a comparable disease to that
in rd1 and rd10 mice. cGMP accumulates in mutant PRs and
eventually triggers cell death via pathways that presumably
involves Ca++ influx through CNG channels in rod OS [47]. As
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in our model, cone PRs, although unaffected by the mutation,
also degenerate secondarily; b) X-linked progressive retinal
atrophy 2 (xlpra2) is the dog homolog of X-linked retinitis
pigmentosa (XLRP). It is an early-onset, rod and cone disease
caused by a 2-bp microdeletion in RPGR exon ORF15 creating
a frameshift and premature stop in the translated protein [16].
The protein localizes to the connecting cilium, and participates
in intraflagellar protein transport. This ciliary protein is essential
for PR viability and plays a role in ciliogenesis, however its
function is not yet entirely understood (reviewed by [48]; c)
early retinal degeneration (erd) results from a mutation in
STK38L which appears to be involved in early PR development
[17,20]. The disease is characterized by abnormal
development and degeneration of rods and cones and, as an
unique feature, by concurrent PR apoptosis or mitosis, and
formation of hybrid rod/S-cone cells [20]. Although the function
of this protein in PRs is presently unknown, recent in vitro
studies indicated that STK38L-mediated Rabin8
phosphorylation appears to be crucial for ciliogenesis [49].
Gene expression profiles using the canine specific qRT-PCR
profiling array described below were determined for age-
matched 3, 5, 7, and 16 wks old normal, rcd1, and xlpra2-
mutants (3 biological replicates/time point/group), as well as
two erd-mutants at 6.4 wks and three at 8.3/9.9 wks of age.
Single expression assays of 38 selected genes (CD40LG,
TRADD, CASP8, IL6, IL10, NTF3, PTPRC, EDN2, EDNRB,
NFKB1, CRX, SAG, CNGB3, CNGA3, BNIP3L, PLAGL2,
ITGB2, RPGRIP1, RPGR, NDUFS4, FADD, SLC25A5,
CNGB1, CNGA1, RPGRORF15, GFAP, OPN1LW, OPN1SW,
RHO, RIPK1, RIPK3, TNFA, XIAP, CCL2, STAT3, TNFRSF1A,
TNFRSF9, ZBTB4) were analyzed in two erd-mutants at 11.9
and 14.1 wks.
Experimental time points
Expression profiles were tested at the most relevant disease-
related phases of PR cell death [19,20]. The 3 wk time point
(induction phase) is at the onset of disease prior to the peak of
PR death, and the retina is comparable in structure to normal.
The disease dependent execution phase at 5 and 7 wks
coincides with the peak of PR cell death, and occurs during or
shortly after the end of complete, albeit abnormal, postnatal
retinal development. During this phase, there is outer segment
disorganization and disruption, but most of the diseased cells
are present suggesting that any detected alterations in gene
expression are likely to represent early degenerative
processes. Lastly, at > 14 wks (chronic cell death) the mutant
retina shows sustained but reduced cell death rate and a
persistent low-grade degeneration.
TUNEL assay and ONL thickness measurement
Cryosections along the superior meridian of rcd1 mutants
were analyzed with TUNEL (terminal deoxynucleotidyl
transferase mediated biotinylated UTP nick end labeling)
assay, as previously reported for xlpra2 [19] and erd [20].
TUNEL positive apoptotic nuclei were visualized with the In
Situ Cell Death Detection kit (Roche Applied Science,
Indianapolis, IN) and stained with 4′,6′-diamino-2-phenylindole
(DAPI). Positive controls included sections pre-treated with
DNase I (3 U/mL in 50 mM Tris-HCl [pH 7.5] and 1 mg/mL
BSA). In negative controls, the terminal transferase enzyme
was omitted from the TUNEL reaction mixture. Sections were
examined from the optic disc to the ora serrata by
epifluorescence microscopy with the 40x objective. TUNEL-
labeled cells in the ONL were counted throughout the entire
length of the section. The number of PRs undergoing cell death
as a function of time was expressed as the number of TUNEL-
labeled PRs per 106 μm2 of ONL. The area of the ONL of each
section was obtained by measuring the entire length of the
ONL, from optic disc to ora serrata, and multiplying it by the
average thickness (measured in three different locations) of the
ONL throughout the section. Each dog was tested in triplicate
with sequential sections from the superior meridian and the
values were averaged and reported as the mean ± SD.
For each dog, a single section from the superior quadrant
was used for quantitative evaluation of ONL thickness,
measured as the number of rows of PR nuclei. Two specific
locations were examined; 2,000 ± 500 µm from the optic disc
and mid point ± 500 µm between optic disc and ora serrata. At
each of these sites, the number of rows of PR nuclei in the
ONL were counted in at least three areas of a 40 field and
averaged.
Canine specific qRT-PCR profiling array
The canine-specific TaqMan qRT-PCR profiling array was
developed in conjunction with Applied Biosystems and
validated on a smaller number of genes using control and
staurosporin-treated MDCK cells [18]. The custom made array
included genes that are present in other commercially available
arrays for other species, and potentially relevant genes
identified from the literature which might have a role in the
studied canine retinal disorders. The array has been
extensively described and the nature of the genes present on
the array was analyzed with the Ingenuity Pathways Analysis
(IPA) program [18].
Details on the updated v4 array are presented in Table S1.
The Table also includes the genes analyzed by single assays
using either TaqMan or SYBR green reagents. For the latter,
the specificity of the primers was confirmed by dissociation
curve procedures as a single melting temperature was
observed which excluded the presence of secondary non-
specific gene products and primer dimers. Genes in the array
were sub-divided into 6 main categories that inform on
signaling pathways and disease mechanisms, according to the
current literature. This is somewhat arbitrary because several
genes fit into different categories depending on various factors,
e.g. cell type, disease, age, interaction with different other
molecules, and because this classification is a dynamic
process that alters as more information becomes available.
The categories were: 1) pro-death, mitochondria-dependent; 2)
pro-death, mitochondria-independent; 3) autophagy; 4) pro-
survival; 5) highly expressed in retina (rods, cones, Müller cells,
astrocytes, bipolar cells); 6) housekeeping.
RNA extraction and qRT-PCR analysis
All the qRT-PCR experiments complied with the MIQE
(Minimum Information for Publication of Quantitative Real-Time
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PCR Experiments [50]) guidelines. Total RNA from retinas was
extracted following standard TRIzol procedures (Invitrogen-Life
Technologies, Carlsbad, CA). RNA concentration was
assessed with a ND-1000 Spectrophotometer (NanoDrop
Technologies, Thermo Fisher Scientific, Wilmington, DE) and
RNA quality verified by microcapillary electrophoresis on an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA) with RNA 6000 Nanochips. Only RNA with RIN> 9 and
A260/280> 1.9 was used.
RNA samples were treated with RNase-free DNase and then
reverse-transcribed using the High Capacity cDNA Reverse
Transcription Kit following standard procedures from the
manufacturer (Applied Biosystems, Foster City, CA). The qRT-
PCR reactions contained 40 ng cDNA, 1x TaqMan Universal
PCR master mix (Applied Biosystems), and 1x custom gene-
specific TaqMan® assay or 900 nM of each unlabeled forward
and reverse primer and 250 nM of FAM dye labeled TaqMan
MGB probe. The SYBR green qRT-PCR reactions contained
40 ng cDNA, 1x SYBR green PCR master mix (Applied
Biosystems), and 250 nM of each unlabeled forward and
reverse primer. Reactions were performed in 96-well arrays
using the 7500 real-time PCR machine and detection software
(v2.0.1, Applied Biosystems).
Quality control and all statistical analyses were computed
with RealTime StatMiner® version 4.0 (Integromics Inc.,
Philadelphia, PA). GAPDH was found to be the most stable
housekeeping gene in all tested samples, and used for
normalization and calculation of the ratio of diseased vs.
normal using the ΔΔCT method [51]. A parametric moderated t-
test, where the standard errors were moderated across all the
genes using a simple Bayesian model and the p-values
adjusted for the Benjamini & Hochberg (BH) step-up false
discovery rate (FDR) controlling procedure, was applied to
verify if the variations between groups were statistically
significant. Genes with BH-adjusted p<0.05 and FC>+/- 2 were
considered DE.
Protein extraction and western blot analysis
Protein extraction and western blot were performed as
previously described [27]. Briefly, for western analyses, protein
extracts (30 µg) were separated by SDS-PAGE (4% stacking
gel, 12% separating gel), and transferred to a polyvinylidene
difluoride membrane (Trans-Blot Transfer Medium, Bio-Rad,
Hercules, CA) in chilled transfer buffer. The membrane was
blocked in 10% skim milk in Tris buffered saline containing
0.5% Tween-20 overnight at 4°C, and then incubated for 1.5 h
with the primary antibodies. The antibodies and concentrations
used are detailed in Table S4. Either ACTB or GAPDH were
used as loading controls. Due to the limited availability of
samples, a single retina per status/time point was analyzed.
For TNFA, recombinant canine TNFA (#1507-CT, R&D
Systems, Minneapolis, MN) was used as positive control and
showed a band at 62 kDa, like the retinal samples, and an
additional band at 17 kDa, where the monomeric form of the
protein is expected. The positive controls for NFkB p65, IKKα/
β, and IKBα were collected from dogs with relapsed B-cell
lymphoma and used in a previously study [52].
Signal was detected by incubating with the appropriate
secondary antibody conjugated with horseradish peroxidase
(1:2,000, Zymed, San Francisco, CA), visualized using the ECL
method according to the manufacturer's recommendations
(ECL Western Blotting Detection Reagents Kit, Amersham,
Piscataway, NJ), and exposed on autoradiograph films
(Eastman Kodak, X-oMAT; Rochester, NY). ImageJ software
(http://rsb.info.nih.gov/ij/index.html; [53]) was used to compare
the intensities of the bands found with western blot analysis.
Band intensities of each protein were normalized with either
ACTB or GAPDH intensities.
Fluorescent immunohistochemistry (IHC)
Seven µm cryosections of OCT embedded retinas from
normal and mutant dogs were used for IHC. The procedures
used for tissue collection, preparation, and sectioning were
previously described [19]. Cryosections were washed and
treated with the primary antibodies at dilutions listed in Table
S4; both single and dual immunolabeling procedures were
done. Antigen-antibody complexes were visualized with
fluorochrome-labeled secondary antibodies (Alexa Fluor,
1:200, Molecular Probes, Eugene, OR) and DAPI stain was
used to label cell nuclei. Slides were mounted with Gelvatol
(Sigma-Aldrich, St Louis, MO) and examined either with an
epifluorescent (Axioplan, Carl Zeiss Meditech, Oberkochen,
Germany) or a confocal microscope (TCS SP5 spectral
imaging confocal/multiphoton, Leica Microsystems, Exton, PA).
Images were digitally captured (Spot 4.0 camera or Leica
Application Suite LAS-AF-Lite 2.6.0, respectively), and
displayed with a graphic program (Photoshop, Adobe,
Mountain View, CA).
Supporting Information
Figure S1.  Retina morphology in study models.
Morphological changes in normal, rcd1, xlpra2, and erd mutant
retinas at different ages (4-4.3, 6-8, and 14.1-16 wks). PR
degeneration occurs at different rates. It is more rapid and
aggressive in rcd1, slightly delayed in xlpra2, while the disease
in the erd model shows preservation of the ONL and no
changes until at least 14.1 wks of age. Scale bar: 20 μm; RPE
= retinal pigment epithelium, PR = photoreceptors, ONL = outer
nuclear layer, OPL = outer plexiform layer, INL = inner nuclear
layer, IPL = inner plexiform layer, GCL = ganglion cell layer.
(TIF)
Figure S2.  Protein co-localization in retina cells of study
models. Co-labeling (yellow) in normal, rcd1, and xlpra2-
mutant retinas at 7 wks with antibodies against proteins
expressed in different retinal cell layers (red: TNF superfamily
ligands TNFA, CD40LG, and TNFSF8; TNF superfamily
receptors TNFRSF1A and TNFRSF9; TNF superfamily adaptor
TRADD; the initiator caspase CASP8; pro-survival molecule
STAT3) and either CRALBP (green - marker for Müller cells),
parvalbumin (green - marker for horizontal and amacrine cells),
or Go-α (green - marker for ON bipolar cells). TNFA, CD40LG,
STAT3, and TNFSF8 are expressed by Müller cells, and the
latter also by horizontal and ON bipolar cells. While TNFRSF1A
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and CASP8 are expressed by a high number of horizontal
cells, few of these cells also express TNFRSF9 and TRADD.
TNFRSF9 is also expressed by amacrine cells. Single
immunolabeling of these proteins at different ages is shown in
Figure 6. Scale bar: 20 μm. Note that the pictures with
parvalbumin were taken by confocal microscopy. A dashed line
indicates that the figure was cut and an asterisk that the RPE
was missing. RPE = retinal pigment epithelium, PR =
photoreceptors, ONL = outer nuclear layer, OPL = outer
plexiform layer, INL = inner nuclear layer, IPL = inner plexiform
layer, GCL = ganglion cell layer.
(TIF)
Table S1.  List of genes tested by qRT-PCR (modified from
[18]). Genes are divided into those present in the profiling array
(v4) or analyzed in single assays, and are reported with their
symbols (in parenthesis the alternative symbols), descriptions,
categories, TaqMan® assay numbers (Applied Biosystems;
http://www3.appliedbiosystems.com/AB_Home/index.htm) or
primer sequences. Main categories were: 1) pro-death,
mitochondria-dependent; 2) pro-death, mitochondria-
independent; 3) autophagy; 4) pro-survival; 5) vision related,
highly expressed in retinal cells: a) PR, b) Müller cells and
astrocytes, c) bipolar cells; 6) housekeeping. SYBR green was
used for FADD, RPGRORF15, and RPGRIP1.
(DOC)
Table S2.  Western blot quantification. ImageJ was used to
quantify the signal intensities of bands found with western blot
analysis for proteins that are retina-specific (RHO, SAG; Figure
3A) or involved in signaling pathways (TNFA, CD40LG,
TNFSF8, TNFRSF1A, TNFRSF9, TRADD, CASP8, STAT3,
NTF3, XIAP; Figure 5). Signal normalization was performed
with either ACTB or GAPDH.
(XLSX)
Table S3.  Differentially expressed (DE) genes identified by
qRT-PCR in study models. DE genes (BH-adjusted p<0.05
and FC>+/-2) between rcd1, xlpra2, and erd-mutants compared
to normals at different ages are divided in photoreceptor (PR)
and retina-enriched or found with the signaling pathway
analysis. They are listed in alphabetical order, first the up-
regulated and then the down-regulated, and are reported with
the FC differences compared to normals. They are separated
in unique for one specific disease or common between different
diseases. In red DE genes that were common for all three
diseases. For the 11.9-14.1 wks erd-mutants a reduced
number of genes (n=38) were tested (see Material and
Methods). The complete list of genes tested is available as
Table S3.
(DOC)
Table S4.  List of antibodies used for
immunohistochemistry (IHC) and western blot (WB).
Antibodies are reported with the corresponding protein symbol,
the source with either catalogue number/manufacturer or
personal gift, descriptions, and concentrations used.
(DOC)
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